CAPR - Capricor Therapeutics beats by $0.03 misses on revenue May, 13 2019 04:01 PM Capricor Therapeutics Inc. Capricor Therapeutics (NASDAQ:CAPR): Q1 GAAP EPS of -$0.08 beats by $0.03.More news on: Capricor Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...